logo

RNXT

RenovoRx·NASDAQ
--
--(--)
--
--(--)
2.45 / 10
Underperform

RNXT's fundamentals score just 2.5/10, flagged by negative Asset-MV and Revenue-MV factors. While Days sales outstanding and Interest coverage ratio offer some relief, the weak profitability and growth metrics suggest limited long-term appeal. A prudent stance is warranted given the sub-par fundamental backdrop.

Fundamental(2.45)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-3.64
Score1/3
Weight8.95%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.90%
1M Return1.11%
Days sales outstanding
Value32.34
Score2/3
Weight1.94%
1M Return1.10%
Profit-MV
Value0.46
Score2/3
Weight17.78%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight17.80%
1M Return8.45%
PB-ROE
Value3.09
Score2/3
Weight22.18%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.78%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.73%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight13.01%
1M Return6.68%
Cash-MV
Value-0.07
Score2/3
Weight17.48%
1M Return8.41%
Is RNXT fundamentally strong?
  • RNXT scores 2.45/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, 0.00% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.